What is Henoch-Schönlein Purpura?
HSP primarily manifests through a distinctive purpuric rash, typically appearing on the lower extremities and buttocks. This rash results from bleeding under the skin due to the inflammation of blood vessels. Other common symptoms include:Incidence and Demographics
HSP predominantly affects children aged 2 to 6 years, with an incidence rate of approximately 20 cases per 100,000 children. While most cases resolve spontaneously without treatment, some children may experience recurrent symptoms or complications that require medical intervention.Diagnosis and Evaluation
Diagnosing HSP involves a thorough clinical evaluation, focusing on the presence of the characteristic rash along with other symptoms. Essential diagnostic procedures include:Treatment Approaches
Treatment for Henoch-Schönlein Purpura at SSMC is tailored to the severity of the condition and may include:Follow-Up Care
Ongoing monitoring is crucial for children diagnosed with HSP, particularly during the first six months post-diagnosis. Regular follow-ups typically involve:Prognosis
The prognosis for most children with Henoch-Schönlein Purpura is generally positive, with many recovering completely without long-term consequences. However, approximately one-third of patients may experience recurrent symptoms within a year of diagnosis.Our Division of Pediatric Rheumatology is led by experienced consultants who specialize in diagnosing and treating a wide range of autoimmune and autoinflammatory diseases in children. We take a comprehensive, patient-centered approach, working closely with a multidisciplinary team of experts to provide the highest quality care.
State-of-the-Art Technology and Innovative Treatments
SSMC is equipped with advanced technology and offers unique treatment options for pediatric rheumatology patients:
Specialized Procedures
Comprehensive Diagnostic Services
By combining expert care, cutting-edge technology, and a patient-centered approach, SSMC is committed to providing the best possible outcomes for children with pediatric rheumatic diseases
Care of the Critically Ill Surgical Patient (CCrISP) is a two-day, interactive course, which includes mandatory, pre-course e-learning. It covers the practical skills and knowledge that health care professionals need to effectively care for surgical patients, including those who are deteriorating or at risk of doing so.